Our aim was to investigate the role of emtricitabine/ tenofovir alafenamide/bictegravir (FTC/TAF/BIC) regimen on metabolic and immune profile.
Immune and metabolic profile in people living with HIV initiating emtricitabine/tenofovir alafenamide/bictegravir
Giovanni Francesco Pellicanò;
2024-01-01
Abstract
Our aim was to investigate the role of emtricitabine/ tenofovir alafenamide/bictegravir (FTC/TAF/BIC) regimen on metabolic and immune profile.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
